Pharmaceutical Schedule
All funded medicines in New Zealand.
Community Schedule
Hospital Medicines (HML)
Schedule Updates
Schedule resources
About the Schedule
Rules of the Schedule
Hospital Medical Devices
Medicine funding and supply
Ask us to fund a medicine | Check changes to medicines | How do generics work?
Make an application
Medicine notices (includes supply issues)
Brand changes, discontinuations and more.
The funding process
What you need to know about medicines
Medicine supply management
Order condoms and nicotine replacement | About supply management
Hospital medical devices
PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices.
What is a hospital medical device?
Devices Schedule
Download the latest hospital medical devices schedule
Category Information
Medical devices we have contracted and the ones we're working on
Our role in hospital medical devices
Device Advice
Read and subscribe to our devices newsletter
Te Tiriti o Waitangi
Te Tiriti o Waitangi policy
Pharmac's Te Tiriti o Waitangi Policy came into effect in November 2022.
Te Whaioranga
Te Pātaka Whaioranga's Māori Responsiveness Strategy
Hauora Arotahi
The Māori health areas of focus
Programmes to support Māori health
Scholarships, awards and programmes
How we work with Whānau Ora
News and resources
Consultations and decisions
includes RFPs and tenders.
News and updates
Official Information Act
Our responses to OIA requests
Publications and resources
COVID-19
Pharmac's research
About
Strategic Direction
Our plan to deliver the best health outcomes for New Zealanders
The Pharmac Review
Access equity
Our work to improve equity of access to medicines in New Zealand.
Pacific Responsiveness Strategy
What we do
Who we are
How we get expert advice
Advice we seek to make decisions
Working at Pharmac
Explore current vacancies
Contact us
How to get in touch
In March 2021 the Government commissioned a review of Pharmac. The Panel delivered its final report to the Minister of Health on 28 February 2022. Pharmac provided its response to the government in November 2022.
